Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
X-press Tag Peptide: N-terminal Leader for Affinity Purifica
2026-05-09
The X-press Tag Peptide is a rigorously validated N-terminal leader peptide widely used for protein purification in recombinant expression workflows. Its unique sequence—including a polyhistidine stretch and Xpress epitope—enables efficient affinity purification and precise detection, with proven solubility and storage parameters (see protocol section).
-
Vitamin C (CAS 50-81-7): Reliable Solutions for Modern Cell
2026-05-09
This article delivers a scenario-driven, evidence-based examination of Vitamin C (CAS 50-81-7) (SKU B2064) for cell viability, proliferation, and cytotoxicity assays. By addressing real laboratory pain points and referencing both published data and product-specific quality metrics, it demonstrates how APExBIO's high-purity Vitamin C enhances reproducibility and workflow reliability for biomedical researchers.
-
Cy5-UTP: Strategic RNA Labeling for Translational Research
2026-05-08
This article provides a thought-leadership perspective on Cy5-UTP (Cyanine 5-uridine triphosphate), illuminating its mechanistic value and strategic impact for translational researchers. Bridging recent advances in RNA probe synthesis, in vitro transcription RNA labeling, and fluorescence in situ hybridization (FISH), we integrate evidence from high-impact studies and discuss how precise fluorescent labeling can reshape the efficiency of nucleic acid delivery, probe analytics, and multicolor expression arrays. The discussion positions APExBIO's Cy5-UTP as a cornerstone for both experimental rigor and translational insight, while critically referencing new findings on lipid nanoparticle (LNP) intracellular trafficking. Protocol parameters, competitive analysis, and a forward-looking outlook on RNA technology are included.
-
Differential Shh, Fgf10, and Fgfr2 Expression in Penile Deve
2026-05-07
Wang and Zheng (2025) reveal key molecular differences in penile development between guinea pigs and mice, implicating the differential expression of Shh, Fgf10, and Fgfr2 in the formation of prepuce and urethral groove. Their work provides a refined model for understanding human penile morphogenesis and highlights the need for appropriate model selection in developmental research.
-
Applied Use of ddhCTP: Antiviral Assays & Workflow Optimizat
2026-05-07
Leverage ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) for robust, reproducible inhibition of RNA virus replication in both traditional and advanced cellular systems. This guide details experimental parameters, practical troubleshooting, and novel insights from recent viperin-nsp8 research, making it essential for antiviral drug development workflows.
-
PD0325901: Precision MEK Inhibitor Workflows in Cancer Resea
2026-05-06
PD0325901 empowers researchers to dissect the RAS/RAF/MEK/ERK pathway with high selectivity, enabling robust cell cycle arrest and apoptosis studies. This article demystifies protocol design, troubleshooting, and cross-study enhancements for leveraging PD0325901 in cell and xenograft models.
-
Lanabecestat (AZD3293) in Alzheimer’s Disease Research Workf
2026-05-06
Lanabecestat (AZD3293) is redefining Alzheimer’s disease research by enabling precise, synaptic-sparing amyloid-beta pathway modulation. This article delivers actionable, evidence-based strategies to optimize experimental design, troubleshoot common issues, and harness the full translational potential of this potent BACE1 inhibitor.
-
Localized Olaparib Nanoparticle Hydrogel for Post-Surgical G
2026-05-05
This study introduces a novel bioadhesive sprayable hydrogel system incorporating polymer-coated nanoparticles of etoposide and Olaparib (AZD2281) for localized drug delivery following surgical resection of glioblastoma. The approach demonstrates improved biocompatibility, sustained drug release, and potential for enhanced therapeutic targeting of residual brain tumor cells, supporting future translational research in localized cancer treatment.
-
(S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon
2026-05-05
(S)-(+)-Dimethindene maleate is a selective M2 muscarinic receptor antagonist optimized for receptor signaling pathway studies in autonomic, cardiovascular, and respiratory research. Use where precise antagonism of M2 and H1 receptors is required and avoid applications outside these validated pathways. Not intended for diagnostic or clinical use.
-
QSHXO Attenuates MASLD via Autophagy and Ferroptosis Modulat
2026-05-04
This study demonstrates that Qushi Huoxue ointment (QSHXO) alleviates metabolic associated steatotic liver disease (MASLD) in mice by activating autophagy and inhibiting ferroptosis. The findings clarify the mechanistic basis for QSHXO's efficacy, providing direction for targeted therapeutic research in liver disease.
-
Neuroligin 1 Loss in Striatal D2-MSNs Drives Repetitive Beha
2026-05-04
This study demonstrates that deletion of Neuroligin 1 in striatal D2 receptor-expressing medium spiny neurons results in their hyperactivation, leading to increased repetitive behaviors in mice. By integrating behavioral, molecular, and single-nucleus RNA sequencing approaches, the authors implicate PKC overactivation and clarify cell-circuit mechanisms underlying core autism symptoms.
-
YM-155 Hydrochloride: Advanced Survivin Inhibitor for Cancer
2026-05-03
YM-155 hydrochloride enables precise, data-driven modulation of survivin in apoptosis inhibitor research, offering nanomolar potency and robust selectivity. This guide details optimized workflows, comparative insights, and troubleshooting strategies that accelerate translational cancer studies with APExBIO’s trusted reagent.
-
Organic Cation Transporter Responses to Xenobiotics in Aedes
2026-05-02
Kennel and Rouhier's 2025 study investigates how Aedes aegypti mosquitoes manage and expel xenobiotic compounds, focusing on the expression of putative organic cation transporters (OCTs/OCTNs) after exposure to synthetic dyes and the mesalamine dimer Olsalazine Sodium. Their findings reveal that while transporter gene expression remains largely unchanged, the chemical structure of xenobiotics substantially influences excretion dynamics and mosquito mortality, pointing to potential molecular targets for vector control.
-
Ibrexafungerp Efficacy Against Fluconazole-Resistant Candida
2026-05-02
This study demonstrates that ibrexafungerp (MK 3118) exhibits consistent in vitro activity against fluconazole-resistant Candida auris and achieves significant efficacy in a delayed-therapy animal model of invasive candidiasis. These results highlight its potential as an oral antifungal for multidrug-resistant Candida infections, where treatment options remain limited.
-
GSK343: Precision EZH2 Inhibitor for Epigenetic Cancer Resea
2026-05-01
GSK343 empowers researchers to dissect PRC2-mediated gene silencing with unmatched selectivity and potency, advancing epigenetic cancer research and stem cell studies. This guide demystifies applied workflows, troubleshooting, and protocol innovations anchored in the latest discoveries on telomerase regulation.